In this study, TGF-β2 production in A2058 cells was significantly downregulated after exposure to ngTASO, and the blockade of TGF-β signaling by ngTASO combined with PD-1 inhibition showed additional tumor growth inhibition in a melanoma-bearing HIS mouse model. The gene discussed is TGFB2; the disease is neoplasm.